---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-078937"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2024-07-10T23:59:59+00:00"
generated_at: "2026-05-31T22:03:58.789565+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Warrant exercise raises $7M for Annovis Bio; 0.8M shares issued

## Summary
- 0.8M November 2023 warrants exercised July 8-9, 2024 at $9.00 per share.
- Gross proceeds of $7.0M from the exercise.
- Approximately 0.8M shares of common stock issued.
- Warrants were part of a prior offering from Nov 1, 2023.

## SEC filing metadata
- accession: 0001104659-24-078937
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2024-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/0001104659-24-078937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/tm2419203d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-078937
- JSON: https://secwatch.observer/filing/0001104659-24-078937.json
- Plain text: https://secwatch.observer/filing/0001104659-24-078937.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.